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INTRODUCTION:  Idiopathic  erythematous  reaction  of the  breast  (Red  breast  syndrome)  is a  known  com-
plication following  breast  reconstruction  with  acellular  dermal  matrix.  However  pustular  dermatitis  like
presentation  is not  previously  known.
PRESENTATION  OF  CASE:  We  present  a 42-year-old  lady  who  developed  bilateral  pustular  dermatitis  like
appearance following  breast  reconstruction  with  acellular  dermal  matrix  slings.  Though  surgical  washout
was done,  both  expanders  and  ﬂex  HD  could  be  preserved.cellular dermal matrix
ed breast syndrome
ustular dermatitis
ase report
DISCUSSION:  Acellular  dermal  matrix  use  is the  only  possible  explanation  for such a  presentation  and  this
can  be considered  a  variant  of  red  breast  syndrome.
CONCLUSION:  Pustular  dermatitis  like presentation  can  be associated  with  acelluar  dermal  matrix  use
and should  be considered  in similar  clinical  presentations,  since  this  can  avoid unnecessary  surgical
procedures.
© 2016  Published  by Elsevier  Ltd.  on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open  access  article
he  CCunder  t
. Introduction
Acellular dermal matrices (ADM) are a group of immuno-
ogically inert dermal replacement products created from
ecellularised cadaveric or xenographic skin. They have become
 common adjunct in implant based breast reconstruction [1–3].
lexHD® PliableTM, (Mentor Worldwide LLC, Santa Barbara, CA
nd Musculoskeletal Transplant Foundation, Edison, NJ) (Flex HD)
s an acellular dermal matrix derived from donated human skin
http://www.ethicon.com/healthcareprofessionals/products/-
ernia-repair-and-ﬁxation/hernia-mesh-biologic-mesh/ﬂexhd-
tructural-acellular-hydrated-dermis#!description-and-specs).
e  have been using Flex HD since early 2014 for breast recon-
tructions. Use of ADM is thought to produce a better cosmetic
esult, reduce operating time and reduce post-operative pain [3,4].
 number of studies have noted high infection rates with the use
f ADM [4–7]. Red breast syndrome (RBS) is a type of cellulitis-like
eaction of unknown aetiology associated with the use of ADM [8].
e report the ﬁrst case of ﬂorid pustular dermatitis in association
ith Flex HD use.
∗ Corresponding author at: Head of Multidisciplinary Breast Service, 102-118
urdoch Drive, Murdoch, WA 6150, Australia. Fax: +61 893824611.
E-mail addresses: drjustinjamesj@yahoo.co.uk (J. James),
ee.jackson@health.wa.gov.au (L. Jackson).
ttp://dx.doi.org/10.1016/j.ijscr.2016.02.040
210-2612/© 2016 Published by Elsevier Ltd. on behalf of IJS Publishing Group Ltd. This 
rg/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Methods
We collected patient information and data on the following clin-
ical course prospectively. Clinical photographs were taken during
hospital admission with written patient consent meeting insti-
tutional guidelines. Patient was  followed up in our clinic after
discharge from hospital. Information is presented here as per CARE
guidelines [9].
3. Presentation of case
A 42 year old lady presented with a self-detected left breast
lump. She had a 40 mm mass in the upper outer quadrant with
clinically palpable lymph nodes in the left axilla. Investigations
conﬁrmed this to be grade 3 hormone receptor positive and HER2
negative invasive ductal carcinoma with axillary node involve-
ment and no distant metastases. She underwent bilateral total skin
sparing mastectomy, left axillary dissection and bilateral tissue
expander (TE) insertion with Flex HD. The TE was  implanted in a
sub pectoral pocket and Flex HD was  used to cover the lower pole
of the TE as a bridge between the inframammary fold and lower
border of pectoralis major. A fat sheet of Flex HD 6 × 16 cm was
used on either side and secured in place using Prolene continuous
sutures. She was  discharged home in a stable condition on the 4th
post-operative day. Twenty four hours after discharge she repre-
sented to the emergency department with redness and multiple
pustules on both breasts. She was  systemically well. Both breasts
is an open access article under the CC BY-NC-ND license (http://creativecommons.
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Fig. 1. Pustular dermatitis of left breast.
Description: appearance of left breast on ﬁfth post-operative day.
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tig. 2. Pustular dermatitis of right breast.
escription: appearance of right breast on ﬁfth post-operative day.
ere red and tender with multiple pustules over both breasts. A
urplish discolouration was obvious over the breast which was
ost pronounced on left. (Figs. 1 and 2). The skin elsewhere was
ormal with no evidence of dermatitis. Her white cell count was
.92 × 109/L and C reactive protein was 120 mg/L (normal range <5).
he was recommenced on IV antibiotics, resuscitated and taken to
heatre for washout with a presumptive diagnosis of infected TE.
t operation there was no evidence of infection or pus formation
eep to skin. Inﬂammation was conﬁned to skin with normal look-
ng subcutaneous and deeper tissues. Sub pectoral pockets were
lean and devoid of any oedema or pus. Sub pectoral and subcu-
aneous pockets were thoroughly washed with antiseptic solution.
oth TE were explanted, washed in antiseptic and antibiotic solu-
ions and re inserted. Irrigation catheters were inserted in to the sub
ectoral pockets, preserving Flex HD. Vancomycin irrigation was
ommenced and continued for the next 3 days. Intravenous antibi-
tic was continued for 7 days. She improved consistently in the next days with disappearance of pustules and complete improvement
f the dermatitis. She was  discharged home on oral antibiotic for
ve more days on the eighth post-operative day. None of the cul-
ures grew any pathogens. She remains well at the end of the secondPEN  ACCESS
gery Case Reports 22 (2016) 59–61
post-operative month without any further episodes of dermatitis
and has commenced adjuvant chemotherapy.
4. Discussion
RBS usually presents with erythema over the breast without any
systemic signs of infection such as fever or leucocytosis [10]. The
exact aetiology of this remains unknown, while a number of causes
such as improper orientation of ADM (ADM is polarized and should
be inserted with smooth surface facing the implant), foreign body
reaction, lymphatic obstruction, hyperaemia secondary to neovas-
cularization and type IV hypersensitivity reactions are postulated
[8,11]. None of the reported description of RBS resembles the ﬂorid
dermatitis seen in our patient. Similar to other reported cases of
RBS our patient was  remarkably well systemically in spite of very
dramatic appearing breast inﬂammation. Even though we used
antibiotic irrigation and IV antibiotics, it is not clear if this was
the reason for the prompt recovery seen in our patient since we
have not been able to demonstrate a causative agent in culture.
It is possible that the skin ﬂaps might have suffered ischaemia as
indicated by purple discolouration seen in the initial stages. How-
ever this completely recovered in the following days without any
skin loss or need for debridement. Whether ischemia has con-
tributed to this appearance is unknown. Overall a non-infective
acute inﬂammatory reaction in the presence of ADM seem to be the
most appropriate explanation for the clinical picture. Even though
a number of reports of RBS are available in the literature, none of
those descriptions seem to report such dramatic appearing skin
inﬂammation. Awareness of such a condition can help in correct
decision making in the future.
5. Conclusion
This paper presents the ﬁrst reported case of a ﬂorid pustular
dermatitis of the breast following reconstruction using ADM. This
has to be considered as a possible explanation for breast inﬂamma-
tion in ﬁtting clinical presentations.
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